Some of the biggest companies in the pharmaceutical sector are preparing relief packages to support the public and healthcare providers to cope with the coronavirus pandemic.
AbbVie announced a $35 million fund providing food and supplies at the end of March, saying:
“AbbVie (NYSE:ABBV), a research-based global biopharmaceutical company, today announced a donation of $35 million to support COVID-19 relief efforts. In the U.S., AbbVie’s funds will be used to support healthcare capacity for hospitals as well as protect vulnerable populations by enabling access to food and essential supplies. In Europe, the donation will provide critical equipment and supplies to patients and front-line healthcare workers in the hardest-hit countries.
“‘AbbVie is making this donation to nonprofit partners that will have an immediate and significant positive impact in communities that have been hit hardest by this unprecedented crisis,’ said Richard A. Gonzalez, chairman and chief executive officer, AbbVie. ‘Our 30,000 AbbVie team members around the world are proud to be able to help make a difference in the fight against this virus.'”
Read AbbVie’s press release here.
Pfizer followed suit on the 6th April, also committing to supporting communities:
“Pfizer Inc. (NYSE: PFE) and The Pfizer Foundation today announced the commitment of $40 million in medical and charitable cash grants to help combat the global health effects of the COVID-19 pandemic in the U.S. and around the world. The donation addresses the urgent needs of partners who are working to slow the spread of the virus within communities and strengthen vulnerable healthcare systems against future public health threats. Pfizer is also responding to patient and healthcare provider needs during this unprecedented time by evolving its U.S. Patient Assistance Program and donating additional critical medicines and vaccines in the U.S. and around the world.”
Read Pfizer’s press release here.
These two companies were not alone in making funding and donations available, with Novartis and others making similar commitments. FiercePharma has reported more on these efforts here.
In the UK, members of the Ethical Medicines Industry Group (EMIG) and the Association of the British Pharmaceutical Industry (ABPI) have been very active in responding to the NHS’ requests for support and supplies, and many staff members have become volunteers for the efforts against coronavirus.